FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
3,819 letters. Newest first.
-
Tobaccoswedishproducts.online
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsA. Nelson & Co. Ltd.
London homeopathic drug maker A. Nelson & Co. shipped children's products without microbial testing and discarded quality records.
High risk -
DrugsAQ USA Inc., d.b.a Ross Healthcare Inc.
FDA warns AQ USA/Ross Healthcare over current good manufacturing practice violations in drugs, including missing microbial testing and inadequate component and stability controls.
High risk -
BiologicsDynamic Stem Cell Therapy
FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.
High risk -
DevicesExThera Medical Corporation
ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.
High risk -
DevicesBeta Bionics, Inc.
FDA says Beta Bionics' iLet Bionic Pancreas system had quality-system failures, including ignored complaints of severe hypoglycemia and diabetic ketoacidosis.
High risk -
TobaccoTombak LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodEast CK Trading Inc.
East CK Trading lacked an FSVP for imported ginseng, wolfberry, and mushroom seasoning, FDA says.
Medium -
DrugsMedisourceRx
MedisourceRx failed to report a serious adverse event and had inadequate procedures, so its compounded drugs lost legal exemptions.
Medium -
DrugsCosmetic Manufacturers Pty Ltd.
FDA warned Cosmetic Manufacturers Pty Ltd. that its Australian drug site was adulterated due to CGMP violations and placed its drugs on import alert.
High risk -
DrugsBertrand P. Cole, D.O.
FDA warns Dr. Bertrand P. Cole that he gave four trial subjects too much drug by not following the study plan.
High risk -
FoodFidelity Melon, Inc
FDA warns Fidelity Melon for lacking foreign supplier verification for imported melons.
Medium -
AnimalElanco Animal Health USA
FDA says Elanco's Pradalex ads misbrand the livestock antibiotic by claiming first-line use and "all relevant pathogen" coverage.
Medium -
BiologicsProDx Health
FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.
High risk -
DrugsBeach Weekend Management LLC dba Nic and Jet Fuel
FDA told Nic and Jet Fuel its nicotine energy drinks are unapproved new drugs sold with drug-like claims.
Medium -
DrugsBio-Medical Pharmaceutical Manufacturing Corporation
Bio-Medical Pharmaceutical Manufacturing, a Houston contract manufacturer, was cited for sterile OTC drug current good manufacturing practice (CGMP) failures and drug listing violations.
High risk -
DrugsMark S. Dacey, M.D.
FDA warns Dr. Mark S. Dacey that a trial subject underwent an optional eye-fluid sampling procedure after twice declining consent.
High risk -
Tobacconiqpouches.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
BiologicsCentral Coast Multispecialty Medical Group, Inc.
FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.
High risk -
BiologicsConceive Fertility Center
FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.
High risk -
BiologicsLouisville Reproductive Center
Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.
High risk -
DrugsSignature Formulations, LLC
FDA says Signature Formulations made OTC drugs on shared equipment without adequate controls, risking hormone contamination.
High risk -
DrugsBoothwyn Pharmacy, LLC
Boothwyn Pharmacy made sterile drugs in insanitary conditions and shipped lots that failed sterility and potency tests.
High risk -
TobaccoBNC Distribution Inc.
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodMaui Seafood LLC
Maui Seafood LLC's Las Vegas RTE tuna and salmon plant had Listeria monocytogenes (a harmful bacterium) and seafood safety plan sanitation violations.
High risk -
Tobaccogotpouches.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsCohance Lifesciences Limited
Cohance Lifesciences, a finished-drug maker, was cited for inadequate investigations and dirty shared equipment that caused cross-contamination.
High risk -
DrugsHTO Nevada, Inc. dba Kirkman
HTO Nevada dba Kirkman, an OTC drug contract manufacturer, was cited for CGMP violations including mislabeled reformulated drugs.
High risk -
DevicesFlextronics America LLC
FDA warns Flextronics America, contract maker of FreeStyle Libre 3 glucose sensors in Austin, TX, over an unvalidated assembly step and weak corrective actions.
High risk -
DevicesAbbott Diabetes Care, Inc.
FDA warns Abbott Diabetes Care that FreeStyle Libre 3 glucose monitors lacked design transfer and finished-device accuracy release testing.
High risk -
FoodThe Great Smart African Food LLC
FDA says Cleveland food importer lacked required import safety plans for maize flour, peanut butter biscuits, and dried milk.
Medium -
FoodChristopher Dale Butler
FDA warned Christopher Dale Butler that his pickled quail egg products lacked required acidified-food process controls and were deemed adulterated (unsafe under the law).
High risk -
FoodCC Pollen Company
FDA warns CC Pollen Company of Glendale, Arizona, that its bee pollen and royal jelly supplements are adulterated and misbranded.
High risk -
DevicesUnomedical Device S.A. de C.V.
FDA warns Unomedical over insulin infusion sets with unvalidated leak tests and unreported serious injuries.
High risk -
FoodEniva USA, Inc.
FDA warns Eniva USA over manufacturing quality failures for Immune Support and Ashwagandha Gummies.
Medium -
FoodCarolina Seafood Inc.
FDA warned Carolina Seafood that its ready-to-eat crab and shrimp dips had inadequate seafood hazard-control plans.
High risk -
FoodZip Foods Importers, Inc
Zip Foods Importers lacked required foreign supplier verification programs for many imported foods, FDA found.
Medium -
DrugsFulijaya Manufacturing SDN. BHD.
Fulijaya Manufacturing in Malaysia failed CGMP (drug manufacturing rules) for OTC drugs, with missing lab data, flawed microbial tests, and weak stability data.
High risk -
DrugsCenter For Immunology Science, LLC
FDA cites Center for Immunology Science for a clinical trial of heat-killed Mycobacterium smegmatis without an Investigational New Drug application.
High risk -
DevicesMeridian Bioscience, Inc
FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.
High risk -
DevicesMAST Biosurgery USA, Inc.
MAST Biosurgery USA never ran promised endotoxin tests on its SurgiWrap FROST surgical mesh and failed to report patient injuries, FDA says.
High risk -
FoodAsli Foods, Inc
Asli Foods, a food importer, lacked required foreign supplier checks for chocolate, tea, and kabab mix, FDA says.
Medium -
FoodMG GROUP USA
MG GROUP USA lacked FSVP records for imported truffle oil and fresh truffles, FDA found during an August 2025 inspection.
Medium -
FoodAmerican Food Distributor Inc.
FDA warns American Food Distributor for missing FSVP for imported tahina, olive oil, and mallow leaves.
Medium -
BiologicsGermaphobix
FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.
High risk -
DrugsProdrome Sciences USA, LLC
Prodrome Sciences studied its supplement ProdromeNeuro Oil as a dementia drug in 29 people without first filing an IND, FDA says.
High risk -
BiologicsGenetrace
FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.
High risk -
BiologicsGenovate
FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.
High risk -
DrugsIntegrity Partners Group
FDA warns Integrity Partners Group about manufacturing failures at its Chemisphere drug plant, including inadequate testing, supplier verification, cleaning, and process validation.
High risk -
DrugsWinder Laboratories, LLC
FDA warns Winder Laboratories of adulterated prescription drugs due to cleaning and facility failures.
High risk